|
ATP5C1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.774810E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.299860E-03 |
| Normal-vs-Stage2 |
3.979900E-03 |
| Normal-vs-Stage3 |
2.824400E-03 |
| Normal-vs-Stage4 |
7.477600E-01 |
| Stage1-vs-Stage2 |
2.818200E-01 |
| Stage1-vs-Stage3 |
3.438000E-01 |
| Stage1-vs-Stage4 |
2.204200E-01 |
| Stage2-vs-Stage3 |
8.301400E-01 |
| Stage2-vs-Stage4 |
7.634000E-02 |
| Stage3-vs-Stage4 |
9.459600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.31840000003625E-06 |
| Normal-vs-AfricanAmerican |
6.730800E-01 |
| Normal-vs-Asian |
7.586800E-01 |
| Caucasian-vs-AfricanAmerican |
3.378100E-02 |
| Caucasian-vs-Asian |
2.622400E-01 |
| AfricanAmerican-vs-Asian |
9.242600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.028000E-04 |
| Normal-vs-Female |
6.063100E-03 |
| Male-vs-Female |
6.692600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.980700E-04 |
| Normal-vs-Extreme_Weight |
1.629500E-04 |
| Normal-vs-Obese |
4.142300E-03 |
| Normal-vs-Extreme_Obese |
9.727200E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.386800E-01 |
| Normal_Weight-vs-Obese |
5.950600E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.530600E-01 |
| Extreme_Weight-vs-Obese |
8.393200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.047400E-01 |
| Obese-vs-Extreme_Obese |
2.075000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.531040E-01 |
| Normal-vs-Age(41-60Yrs) |
1.709920E-02 |
| Normal-vs-Age(61-80Yrs) |
7.70790000000909E-05 |
| Normal-vs-Age(81-100Yrs) |
5.96029999999637E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.834400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.940000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.509000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.100000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.076100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.044560E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.940900E-03 |
| Normal-VS-Type2 PRCC |
1.856780E-03 |
| Normal-VS-KIRP CIMP |
5.807700E-04 |
| Normal-VS-Unclassified PRCC |
6.197100E-04 |
| Type1 PRCC-VS-Type2 PRCC |
7.093000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.479400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.746800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.002200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.975000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.379800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.429300E-04 |
| Normal-vs-N1 |
4.482400E-01 |
| Normal-vs-N2 |
2.478800E-03 |
| N0-vs-N1 |
7.321600E-01 |
| N0-vs-N2 |
2.365600E-01 |
| N1-vs-N2 |
5.683600E-01 |
|
|
